[go: up one dir, main page]

HK1167398A - 作為抗癌症劑的5-取代的喹唑酮衍生物 - Google Patents

作為抗癌症劑的5-取代的喹唑酮衍生物 Download PDF

Info

Publication number
HK1167398A
HK1167398A HK12108121.1A HK12108121A HK1167398A HK 1167398 A HK1167398 A HK 1167398A HK 12108121 A HK12108121 A HK 12108121A HK 1167398 A HK1167398 A HK 1167398A
Authority
HK
Hong Kong
Prior art keywords
halo
disease
optionally substituted
alkyl
methyl
Prior art date
Application number
HK12108121.1A
Other languages
English (en)
Other versions
HK1167398B (zh
Inventor
George W. Muller
Hon-Wah Man
Original Assignee
Celgene Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celgene Corporation filed Critical Celgene Corporation
Publication of HK1167398A publication Critical patent/HK1167398A/zh
Publication of HK1167398B publication Critical patent/HK1167398B/zh

Links

HK12108121.1A 2006-09-26 2012-08-17 作為抗癌症劑的5-取代的喹唑酮衍生物 HK1167398B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60/847,471 2006-09-26

Publications (2)

Publication Number Publication Date
HK1167398A true HK1167398A (zh) 2012-11-30
HK1167398B HK1167398B (zh) 2018-03-16

Family

ID=

Similar Documents

Publication Publication Date Title
EP2428513B1 (en) 5-substituted quinazolinone derivatives as anti-cancer agents
US9834538B2 (en) 6-, 7-, or 8-substituted quinazolinone derivatives and compositions comprising and methods of using the same
HK1167398A (zh) 作為抗癌症劑的5-取代的喹唑酮衍生物
HK1167399A (zh) 作為抗癌症劑的5-取代的喹唑酮衍生物
HK1167399B (zh) 作為抗癌症劑的5-取代的喹唑酮衍生物
HK1167397B (zh) 作為抗癌症劑的5-取代的喹唑酮衍生物
HK1167398B (zh) 作為抗癌症劑的5-取代的喹唑酮衍生物